<DOC>
	<DOCNO>NCT00148746</DOCNO>
	<brief_summary>The study design test hypothesis whether standardized , time-and score-oriented treatment follow strict evidence base algorithm equally effective standard treatment regimen moderate severe atopic dermatitis . Study Type : Mono-centre study , patient blind , physician randomize either treat study- controll group Eligible patient age 2 year old SCORAD &gt; = 20 Duration : 12 Months , study visit every 4 week . Primary endpoint Difference Baseline SCORAD mean SCORAD treatment . Secundary endpoint quality life , safety economic burden treatment group .</brief_summary>
	<brief_title>Standardized Time- Score-oriented Treatment Moderate Severe Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Pimecrolimus</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<criteria>Moderate severe atopic dermatitis ( SCORAD 20 ) fulfilling diagnostic criterion Raika Hanifin Pregnancy Nursing Women childbearing age without contraception Drug alcohol abuse Gene defect associate increase light sensibility , e.g . Xeroderma pigmentosum , Cockayne Syndrome , Bloom Syndrome</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>atopic dermatitis , atopy</keyword>
</DOC>